| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
High Susanna Gatti is a Chief Operating Officer at Dyne Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 20 sells.
Estimated insider holdings value: $2.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2024 | DYN Dyne Therapeutics, Inc. | Chief Operating Officer | Sell | 8,976 | $34.41 | $308,864.16 | -3.2% | -23.8% | -59.5% | |
| Sep 11, 2024 | DYN Dyne Therapeutics, Inc. | Chief Operating Officer | Sell | 5,270 | $31.89 | $168,060.30 | -1.8% | -13.1% | -59.6% | |
| Aug 19, 2024 | DYN Dyne Therapeutics, Inc. | Chief Operating Officer | Sell | 2,910 | $45.12 | $131,303.82 | -1.0% | -36.4% | -73.4% | |
| Jun 24, 2024 | DYN Dyne Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 39,950 | $35.09 | $1,401,901.66 | -11.8% | -2.8% | -70.2% | |
| Jun 12, 2024 | DYN Dyne Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 40,000 | $33.36 | $1,334,200.92 | -11.4% | -1.8% | -56.2% | |
| Jun 11, 2024 | DYN Dyne Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 85,270 | $30.30 | $2,583,782.10 | -15.8% | +4.9% | -52.9% | |
| May 16, 2024 | DYN Dyne Therapeutics, Inc. | Chief Operating Officer | Sell | 2,738 | $28.27 | $77,402.31 | -0.9% | +52.6% | -58.9% | |
| Mar 11, 2024 | DYN Dyne Therapeutics, Inc. | Chief Operating Officer | Sell | 29,491 | $26.59 | $784,247.99 | -5.8% | +23.3% | -52.9% | |
| Mar 7, 2024 | DYN Dyne Therapeutics, Inc. | Chief Operating Officer | Sell | 1,591 | $25.85 | $41,127.35 | -0.8% | +24.4% | -53.1% | |
| Dec 11, 2023 | DYN Dyne Therapeutics, Inc. | Chief Operating Officer | Sell | 1,616 | $10.72 | $17,323.52 | -0.9% | +134.4% | +159.9% |